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Background: Data estimating the recurrence and risk of death are lacking in low and middle income countries,
where two thirds of the stroke burden occurs. Previously we had shown that the incidence and mortality have been
decreasing over the last 18 years in Joinville, Southern Brazil. In this study, we aim to determine the recurrence rates,
survival rates and the cause of death in 3 years after their first-ever incident in a urban population-based setting.
Methods: From the Joinville Stroke Registry, we identified all the cases of first-ever stroke that occurred from October
2009 to September 2010. Multiple overlapping sources of information were used to ensure the completeness of case
identification. Patients were followed up prospectively at regular intervals from 30-days to 3 years after the index event.
Kaplan-Meir and Cox proportional hazards were used to assess the cumulative risk of death and recurrence.
Results: We registered 407 first-ever stroke patients. After 3 years, 136 (33%) had died. In the first year of stroke the risk
of death was 28% (95% CI, 25 to 32). Beyond the first year, approximately 3 to 5% of survivors died each year. The
cumulative risk of death in ischemic stroke (IS) subtypes was 3.6 higher for cardioembolic (CE) IS (hazard ratio 3.6,
95% CI, 2.1 to 6.4; p = 0.001) and 3.3 times higher for undetermined IS (HR 3.3, 95% CI 1.9 to 5.8; p = 0.001) compared
to small artery occlusion IS. Over 3 years, the overall stroke recurrence risk was 9% (35/407). We found no difference in
stroke recurrence risk between IS subtypes. Cardiovascular disease was the main cause of death all follow up time.
Conclusions: Compared to other cohort studies conducted between 10 and 20 years ago in high-income countries,
our recurrence rates and 3-year risk of death were similar. Among IS subtypes, we confirmed that CE has highest risk of
death. The most common cause of death after a first-ever stroke is cardiovascular disease. This has implications for the
uptake of current secondary preventive strategies and the development of new strategies.
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Stroke is the second most common cause of death and
the third most common cause of disability-adjusted life-
years (DALYs) worldwide in 2010 [1,2]. Incidence rates,
30-day case-fatality data, stroke survival rates and recur-
rence risks are useful epidemiological data which help to
understand how well our primary prevention, quality of
hospital care and secondary prevention have been con-
ducted [3]. The overall burden of disease data from the
World Health Organization shows stroke is still in the
top 6 based on disability adjusted life-years [4]. There-
fore, a comprehensive secondary prevention campaign* Correspondence: norbertocabral@icloud.com
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creativecommons.org/publicdomain/zero/1.0/should target the prevention of stroke recurrence, vascu-
lar dementia and death [5,6].
Recurrence and survival rates are useful data to com-
pare the natural history of a disease against the effect of
therapeutic interventions. In community-based studies
which included all major stroke types together, the 3-
year cumulative risk of recurrent stroke has been re-
ported to be varied from 6 to 25% [7-10]. The reported
cumulative risk of death in population-based studies
which included all stroke types ranged across the last three
decades in high and middle-income countries. In the
1980s in the UK, the 1-year risk was 31% and the 5-year
risk was 50% [7]. In the 1990s, in Australia, the 1-year risk
was 38% and the 5-year risk was 60%; [8]. In the 2000s, in
Belarus, the 1-year risk was 38% and the 5-year risk wasticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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based study has been conducted in a South American
country, where the stroke burden is huge.
As we had shown that the incidence of stroke, 30-day
case-fatality and mortality had fallen by a third in Joinville,
Southern Brazil in the last decade [12] (1995 to 2005),
we now aimed to know the stroke recurrence behavior
in our population. Therefore, we conducted a prospect-
ive community-based study of a cohort of patients after
their first-ever stroke to determine the 3-year survival
rates, levels of recurrence and the major causes of death
in Joinville, Brazil.
Methods
Study design and population
This is a population-based prospective cohort study.
Using the Joinville Stroke Registry, an ongoing
population-based registry was established in 2005. We
ascertained all the cases of first-ever stroke occurring
among patients living in Joinville city, Southern Brazil,
between October 1, 2009, and September 30, 2010. This
cohort was then followed up until September 30, 2013.
On the basis of intercensus data, the estimated popula-
tion of the study area was 509,743 inhabitants who lived
in area of 1130 km [2,13]. Joinville city has four hospi-
tals, three intermediate care units and one public institu-
tional care facility. All the hospitals have computed
tomography (CT) services available on a 24-hour basis.
Two thirds of the city population uses only the public
health system, which consists of nine state-run health
districts with 56 primary care facilities.
Baseline assessment
The cohort methods have been described elsewhere [12].
In brief, we used multiple overlapping data sets includ-
ing medical records from all city hospitals, death certifi-
cates, and outpatient monitoring in the state-run and
private units (WHO STEPS) [14,15]. Three research
nurses discussed all the stroke cases occurring in all the
hospitals with a neurologist on a daily basis. On a weekly
basis, a neuroradiologist unaware of patients’ symptoms
analyzed all brain CT scans, magnetic resonance images
and digital angiographies. Every month we analyzed all
death certificates (DC) issued by the Municipal Depart-
ment of Health. We initially selected all death certifi-
cates containing any references to the tenth revision of
the International Classification of Diseases (ICD-10)
codes related to stroke (I61 through I69) or any descrip-
tions of cerebrovascular diseases, as well as those listing
the death as being from an unknown cause (R99). The
deaths of patients not identified on hospitals records
were investigated through the evaluation of hospital
medical charts and, when available, imaging examina-
tions. Every week the state-run health units searchedtheir electronic records for any stroke-related diagnoses
listed in the ICD-10. This happened monthly at the in-
stitutional care facility. However, not all patients identi-
fied agreed to be admitted. Such patients were offered an
appointment as outpatient (1 or 2 per month, usually
minor strokes or a stroke mimics). These records were
reviewed and when necessary each medical chart was late
discussed with a neurologist (NLC). Private city physicians
received a reminder sticker with each study contact.
Stroke definition and cohort criteria
Stroke was defined according to World Health
Organization (WHO) definitions [16]. Ischemic stroke
subtypes were classified according TOAST classification
[17]. The primary outcomes were death or stroke recur-
rence. We defined recurrent stroke as new stroke event,
additionally requiring a period of neurological stability
of ≥24 hours between index and recurrent stroke, and
the exclusion of other potential causes of neurological
deterioration [18]. Individuals who had suffered the sec-
ond stroke event were again interviewed in order to
identify the subtype of the stroke recurrence. All surviv-
ing patients were followed-up through telephone calls by
a research nurse of the Joinville Stroke Registry at 1, 6, 12,
24 and 36 months after the event. They also had face-to-
face meetings with their neurologist or general physician.
We classified the causes of death using standardized diag-
nostic criteria for stroke [16], recurrent stroke [18], myocar-
dial infarction and other vascular death, and nonvascular
death (see definitions, below) [19].
Cohort inclusion and exclusion criteria
We included all the cases of residents of Joinville, re-
gardless of age, diagnosed with any type of first-ever is-
chemic stroke (IS), primary intracerebral hemorrhage
(PIH) or subarachnoid hemorrhage (SAH). We also in-
cluded residents in the city with confirmed strokes that
occurred outside the city limits. Patients experiencing a
stroke for the first time who had experienced a previous
transient ischemic attack (TIA), were also classified as a
first-ever stroke case. We excluded TIA diagnoses, all re-
current events, and stroke patients who died in the first
24 hours of onset, as well as patients residing outside
the Joinville city limits, or patients with subdural, epi-
dural or intracerebral hemorrhage secondary to arterio-
venous malformation or tumors.
Stratification types of deaths
We classified the causes of death into the 5 groups that
were used in the Oxfordshire Community Stroke Project:
[7] (1) deaths resulting from a first-ever stroke due to the
direct effects of a brain lesion or complications of resulting
immobility, including deaths from bronchopneumonia
even if they occurred several years after the stroke if the
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(2) deaths resulting from recurrent stroke that were dir-
ectly due to a brain lesion or complications of immobility;
(3) deaths caused by cardiovascular events that were defin-
itely or probably from myocardial infarction, ruptured aor-
tic aneurysms, peripheral arterial disease, or sudden death
when there was no alternative explanation; (4) deaths
from nonvascular events that were not due to any
stroke-related disability and included such illnesses as
cancer, injuries, or suicide; and (5) deaths of undeter-
mined cause where there was insufficient information
to establish a cause.
Statistical analysis
We performed descriptive statistical analysis to compare
baseline characteristics using the qui-square test, the
Student t test, or the Mann–Whitney test according to
distribution. The Kaplan-Meier product-limit technique
was used to generate survival probabilities and survival
curves. The risk ratio was estimated by using the Cox
proportional model and the Log-Rank test to compare
survival curves among stroke types. We used the R Pro-
ject for Statistical Computing program version 3.1.1.
The study was approved by the ethics in research com-
mittees of the Hospital Municipal São José, the Hospital
Regional, the Centro Hospitalar Unimed, the Hospital




We identified 727 patients with stroke from October 1,
2009 to September 30, 2010. Of those, 225 had priorFigure 1 Flowchart of stroke recurrence or death over 3 years after first-evstrokes, 63 were TIA events, nine patients died in the
first 24 hours and 23 patients moved to other cities.
These 320 patients were excluded. Therefore, the final
cohort sample was 407 patients, among whom 83%
(336/407) suffered ischemic strokes, 11% (43/407) had
primary intracerebral hemorrhages and 7% (28/407) ex-
perienced subarachnoid hemorrhages (Figure 1).
The mean age of these patients at baseline was 63 ±
16 years, with a median age of 64 years. The ischemic
stroke subtypes distribution by TOAST classification
were: 27% (92/336) small artery occlusion (SAO); 27%
(91/336) undetermined (UND); 25% (84/336) cardioem-
bolic (CE); 17% (57/336) large artery atherothrombotic
(LAA) and 4% (12/336) other determined strokes (OD).
Table 1 shows the baseline characteristics, premorbid
medications and premorbid risk-factor prevalence
among IS, PIH and SAH patients.
Outcome at 3 years
Absolute Risks for All Patients
Surviving patients were followed-up for a minimum of
3 years and up to 3 years and 11 months. Over 3 years
of follow-up, 136 died and 35 had a recurrent stroke.
Table 2 and Figure 2 shows that the 3-year cumulative
risk of death was 33.4% (95% CI, 28.9 to 38.3). The risk
of death was greatest in the first year after stroke (24.1%;
95% CI, 20.0 to 29.0) and particularly in the first 30 days
after stroke (21.6%; 95% CI, 17.7 to 25.9). Beyond the
first year, approximately 3 to 5% of survivors continued
to die each year. No patient was lost to follow-up.
Absolute risks for subgroups As expected, stratifica-
tion by the type of the first-ever stroke showed thater stroke in Joinville, Brazil.
Table 1 Premorbid cardiovascular risk factors and
medications in patients with first ever ischemic stroke,
primary intracerebral hemorrhage and subarachnoid
hemorrhage, Joinville 2009-2010
IS (n = 336) PIH (n = 43) SAH (n = 28)
Baseline characteristics
Men 189 (56%) 19 (44%) 14 (50%)
Age, in years, mean (SD) 63 (16) 62 (16) 60 (13)
Premorbid medication
Antiplatelet agent 102 (30%) 5 (12%) 3 (11%)
Anticoagulant 12 (4%) 2 (5%) 0 (0%)
Lipid lowering agent 59 (18%) 5 (12%) 6 (21%)
Premorbid risk factor
Total cholesterol
Mean baseline (mg/dl) 191 (46) 184 (30) 196 (57)
Proportion≥ 6 mmol/L 45 (16%) [1] 2 (8%) [2] 2 (33%) [3]
Systolic blood pressure
Mean (SD) 144 (27) 166 (36) 142 (25)
Proportion≥ 150 mmHg 106 (39%) [4] 14 (56%) [5] 7 (32%) [6]
Proportion≥ 160 mmHg 80 (29%) 9 (36%) 3 (14%)
Diastolic blood pressure
Mean (SD) 87 (16) 95 (21) 88 (14)
Proportion≥ 90 mmHg 69 (26%) [7] 10 (44%) [8] 6 (29%) [9]
Proportion≥ 100 mmHg 30 (11%) 7 (30%) 1 (5%)
Smoking
Current 67 (20%) 9 (21%) 12 (43%)
Ex 102 (30%) 14 (32%) 4 (14%)
Never 168 (50%) 20 (47%) 9 (32%)
Diabetes 78 (23%) 5 (12%) 2 (8%)
Atrial fibrillation 38 (11%) 5 (12%) 0 (0%)
Myocardial infarction 32 (9%) 2 (5%) 1 (4%)
IS: ischemic stroke; PIH: primary intracerebral hemorrhage; SAH: subarachnoid
hemorrhage; Total cholesterol data were available in: [1] (286); [2] (26) [3] (6);
Systolic blood pressure in: [4] (272) [5], (25) [6], (22); Diastolic blood pressure
in: [7] (269) [8], (23) [9], (21).
Table 2 Kaplan-Meier estimates of probability of survival with
1 day to 30 days 1 to 6 months
Risk of death %* 21.6 2.9
CI 95% (17.7-25.9) (1.4-5.4)
Cumulative risk, % 21.6 24.1
CI 95% (17.7-25.9) (20.0-29.0)
Number at risk 407 319
Number of deaths 88 10
Cumulative deaths 88 98
*Risk of death = (1-Kaplan-Meier estimate).
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stantially greater number of case fatalities. The 30-day
case-fatality rate was 54% (12/28) in SAH, 37% (16/43]
in HS and 12% (40/336) in IS patients. After the first
month the cumulative risk of death for all stroke types
decreased. Up to 3 years the cumulative risk of death
was 54% (15/28) in SAH, 53% (23/43) in PIH and 27%
(92/336) in IS. Figure 3 compares the survival probabil-
ities between IS, PIH and SAH.
Among IS sub-types, the 30-day case-fatality was 22%
(20/91) in UND, 18% (15/85) in CE, 9% (1/11) in OD,
2% (2/92) in SAO and also 2% (1/57) in LAA. Figure 4
compares the survival curve among IS over 3 years
(other determined data was not included). Compared to
small artery occlusion, cardioembolic stroke carried a
3.6 times greater risk of death (HR 3.6, 95% CI, 2.1 to
6.4; p = 0.001) and undetermined stroke had a 3.3 times
greater risk of death (HR 3.3, 95% CI 1.9 to 5.8; p =
0.001). Data are shown in supplementary Table 1.
Over three years we identified a cumulative risk of 9%
(35/407) for stroke recurrence. Of those, 17% (6/35)
died. We found no difference in stroke recurrence rates
between IS subtypes (Figure 5).
Figure 6 shows the causes of death at different time in-
tervals after a first-ever stroke onset. During the first
30 days, 90% of deaths were due to the direct neuro-
logical effects of the index stroke. Among 30-day survi-
vors up to 3 years, 71% of subsequent deaths were due
to the first-ever (64%) or a recurrent (7%) stroke, and
23% were due to other cardiovascular causes. Among 3-
year survivors, 43% of subsequent deaths were due to
the first-ever (14%) or a recurrent (29%) stroke, and 7%
were due to other cardiovascular causes.
Discussion
We identified 407 first-ever stroke cases in 2009–10 in
Joinville, Brazil. Over the next 3 years, the recurrence
rate was 9%, with no difference in the recurrence risk
among IS subtypes. As expected, the absolute risk of
death was higher in the first 30 days (22%), decreasing
to 3% to 5% in the following 3 years. Therefore, a sixthin defined time intervals after the index stroke








Figure 4 Kaplan-Meier curve showing the 3-year probability of
survival after first-ever large artery atheroatherotsclerosis (LLA),
cardioembolic (CE), undetermined (UND) and small artery occlusion
(SAO) ischemic stroke.
Figure 2 Kaplan-Meier curve showing the 3-year probability of
survival after a first-ever stroke derived from Joinville Stroke Register,
2009–10. Dots on either side of the solid line indicate 95% CIs;
n indicates number at risk at the beginning of each year.
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3 years. The 30-day case-fatality rate consisted of more
than a half of SAH patients, more than a third of PIH
patients and 12% of IS patients. Despite the lower case-
fatality rate among IS patients, the risk of death was veryFigure 3 Kaplan-Meier curve showing the 3-year probability of
survival after a first-ever stroke among primary intracerebral
hemorrhage (PIH), sub-arachnoid hemorrhage (SAH) and ischemic
stroke (IS).distinct among IS subtypes, where CE and undetermined
IS had a worse prognosis than the other IS subtypes. In-
deed, the 30-day case-fatality rate was 22% in undeter-
mined IS and 18% in CE, whereas we found 9% in other
determined IS cases and 2% in SAO and LAA strokes.Figure 5 Kaplan-Meier survival curve showing the probability that,
given survival, a patient with a stroke will remain free of a recurrent
stroke, stratified by IS subtype (other determined IS not included).
Figure 6 Histogram showing the proportion of patients dying from different causes during different time intervals from the onset of their
first-ever stroke.
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found CE and undetermined IS were the most lethal
among IS subtypes. Three years after stroke onset, CE is-
chemic stroke patients had a 3.6 times higher risk of
death, and undetermined IS patients had a 3.3 times
higher risk of death than those with small artery occlu-
sion (p < 0.001). The 136 deaths observed in the follow-
up period included all causes of death. However, most of
these were caused by cardiovascular complications in
the brain or in the heart. Indeed, intracranial hyperten-
sion and immobility complications from the first-ever
stroke, a recurrence, or an acute myocardial infarction
were responsible for 90% of deaths within 30 days, 100%
of those who died within a year and 50% of those who
died within 3 years.
As far as we know, there are no other stroke survival
or recurrence cohort studies in a community-based set-
ting from low or middle-income countries. Our results
were similar to other cohorts, which included all major
stroke types conducted between the 1980s and the 2000s
in high-income countries [8-11,22,23]. For example, in a
meta-analysis with 9115 survivors from 13 studies, the
pooled cumulative risk of stroke recurrence was 3.1%
(95% CI, 1.7– 4.4) at 30 days, 11.1% (95% CI, 9.0 –13.3)
at 1 year and 26.4% (95% CI, 20.1–32.8) at 5 years [24].
At 3 years, our recurrence rate was 8.6% (95% CI, 6.1-
11.7). A cohort from Oxfordshire reported that the risk
of early recurrent stroke was highest in patients with
LAA, a finding that supports the need for urgent carotid
imaging and prompt endarterectomy [24]. However, as
in other studies we did not find a higher pattern of
stroke recurrence among major stroke types or IS sub-
types [9,11,19,20,23].
In Joinville, the one-year cumulative risk of death after
a first-ever stroke was 28% (95% CI, 25% -32%) and 33%
(95% CI, 29% -38%) after 3 years. Compared with other
cohorts which also included SAH, PIH and IS in their
samples, our rates are significantly lower than in
Oxfordshire, UK (1-year: 44%, 95% CI 41-48%; 3-years:
50%, 95% CI, 46% -54%) [7] and in Perth, Australia (1-year:43%, 95% CI, 38%-48%; 3-years:50%, 95% CI, 44% -54%)
[9]. several authors have studied prognostic factors for
long-time survival rates after stroke [10,25]. It is well stab-
lished that old age and severe impairment after stroke pre-
dict poor outcomes [24,26]. We have not stratified our
sample by stroke severity but one explanation for our lower
risk of cumulative death might be related to lower patient
age. The Joinville mean age was 63 (SD 16) years old, lower
than 72 (SD not specified) years old in Oxfordshire and 73
(SD 13) years old and in Perth [7,8,12,22]. Therefore, the
older age for first-ever onset in UK and Australia might
contribute to a worse death rate in these populations, albeit
the CI rates overlapped with our sample. Joinville has been
using IS thrombolysis in most city hospitals since 2005 and
in its stroke unit since 2000 [26,27]. Of course we cannot
measure with accuracy how much these interventions,
coupled with new drugs for secondary prevention which
became available in the last 20 years, might be related to
our better results.
There are limitations to our study. First, no patient
agreed to an autopsy. Despite the fact that we double-
checked each cause of death by phone and by death cer-
tificate analysis, we had no autopsy data. In contrast, the
Hisayama cohort did an autopsy in 82% of their sample
[28]. Although the proportion of cases was not specified,
the Oxfordshire and Perth cohorts reported they also car-
ried out autopsies [7,8]. Second, we believe that our data
on the proportion of stroke recurrence might be underde-
termined because it is possible that we missed some mild
strokes that were not treated in hospitals. To avoid the
capture of mild cases, we have been use the third step of
WHO Stepwise surveillance criteria [14]. However, we
believe that this strategy is inferior to the face-to-face
follow-up meetings reported in Hisayama, South London,
Oxfordshire, Perth, Erlangen and Melbourne studies
[7,8,10,28,29]. Our strengths are the novelty of this data in
low and middle-income countries. Our Registry is an on-
going state-run program so we have the ability to go back
and measure the trends of recurrence and mortality risk in
the near future in Joinville.
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Within a community-based study design, we have con-
firmed that our recurrence rate are similar to other
population-based studies. Our cumulative risk of death
is lower than other cohorts with the same inclusion cri-
teria, which were however conducted between one and
two decades ago. As with many other authors, we also
found that CE and undetermined strokes have a worse
prognosis than other IS subtypes. Further studies in pop-
ulations with similar socioeconomic profiles need to be
do done in order to compare our results and to help in
planning health policies for secondary stroke prevention.
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